Rexahn Pharmaceuticals Granted European Patent for Novel Anti-cancer Isoquinolinamine Compounds Sep 26, 2012
Rexahn Pharmaceuticals to Present at the Rodman & Renshaw 14th Annual Healthcare Conference Sep 6, 2012
Rexahn Pharmaceuticals Announces Positive Top-line Phase IIa Data for Archexin in Patients with Metastatic Pancreatic Cancer Aug 28, 2012